Recombinant DNA Technologies

Recombinant DNA Technologies We provide strategic and technical guidance for all BioProcessing needs.

I have found myself recommending this approach more often in recent years. Last week I spoke with a client who was consi...
06/15/2026

I have found myself recommending this approach more often in recent years. Last week I spoke with a client who was considering buying several bioreactors and was torn between new and used. I suggested they call Camber Road or Farnham Street and explore a lease.

Build vs. Buy Isn't the Only Choice One of the classic project management decisions is build versus buy. Do you develop a capability internally, or outsource it to someone else? The answer often comes down to the same tradeoffs: cost, time, and quality. It's the Iron Triangle. In my career, I have o...

Most discussions about morale focus on motivation.In my experience, morale problems are often confidence problems.Teams ...
06/09/2026

Most discussions about morale focus on motivation.

In my experience, morale problems are often confidence problems.
Teams lose confidence when they can no longer connect effort with outcome.

Information is the Root of Morale June 8, 2026 Morale is an emotional response to what people believe about progress. When people are constantly asking themselves: The resulting morale problem isn’t about motivation. It’s about confidence. A difficult milestone vs. A non-credible milestone Teams...

Assay conditions are not neutral.They determine what biology youre able to see.One lesson l've seen repeatedly across hi...
06/04/2026

Assay conditions are not neutral.

They determine what biology youre able to see.

One lesson l've seen repeatedly across high-throughput screening, synthetic biology, and industrial biotech:

You always get what. you screen for.

https://www.linkedin.com/posts/bwolner_high-throughput-screening-is-often-treated-share-7467293821404557312-KDbm/

High throughput screening is often treated as a straightforward exercise. You build an assay around the hits you want to find - binding partners, enzyme activity, phenotypes. Most of the focus goes toward throughput. How do you screen more candidates, faster? But assay conditions are not neutral. Th...

Scaling in biotech is hard. The cost of putting steel in the ground is high. Some companies have considered repurposing ...
06/01/2026

Scaling in biotech is hard. The cost of putting steel in the ground is high. Some companies have considered repurposing existing infrastructure. It makes sense but has its own challenges.

CAPEX can be a killer in industrial biotech. For years, companies have explored repurposing breweries, ethanol plants, and other fermentation infrastructure rather than rebuilding capacity from scratch. On paper, it sounds logical. But retrofitting biological processes is often far more complicated....

Having helped companies working on the gut microbiome/cancer therapeutic relationship, I am excited to see the field mov...
05/28/2026

Having helped companies working on the gut microbiome/cancer therapeutic relationship, I am excited to see the field moving from correlations to mechanisms.

Gut microbiome and cancer therapeutics. It’s a fascinating relationship. I’ve advised companies working in this area, read papers, and followed the topic for years. One observation keeps coming up: responders and non-responders often have different microbiome compositions. That led to the obviou...

Business are Complex Adaptive Systems. But sometimes adaptation can become drift.
05/26/2026

Business are Complex Adaptive Systems. But sometimes adaptation can become drift.

I’ve seen biotech teams mistake changing conditions for a reason to continually redefine direction. Sometimes adaptation is necessary - markets shift, funding environments change, and technical assumptions fail. Good captains adjust to weather, but resilient organizations still maintain a coherent...

It's important to stop and check your bearings.Especially when things are moving quickly.
05/18/2026

It's important to stop and check your bearings.
Especially when things are moving quickly.

Before GPS, captains regularly checked their bearings. Not because they expected catastrophe. But because even small deviations compound over time. I think about this often in biotech R&D. Markets shift. Requirements change. Early assumptions prove false. New data can look promising yet still lead t...

I love sailing. And books about sailing. Patrick O'Brian's Master and Commander series about Jack Aubrey provide many li...
05/15/2026

I love sailing. And books about sailing. Patrick O'Brian's Master and Commander series about Jack Aubrey provide many life lessons.

Good captains don’t fight every battle available to them. That’s a recurring lesson in Patrick O’Brian’s novels - and in leadership more broadly. Sometimes the conditions are wrong. Sometimes the ship isn’t ready. Sometimes the crew is exhausted. Sometimes the risk outweighs the prize. And...

Latest article on leadership
05/14/2026

Latest article on leadership

“It’s easier to set a course than to correct one.” It’s a cliché. But it’s also an aphorism - the kind of phrase that survives because it expresses something true. In Project Management, we learn that “the cost of change increases with time.” There are two reasons why: First, the long...

Address

169 Saxony Road
Encinitas, CA
92124

Opening Hours

Monday 10am - 5pm
Tuesday 10am - 5pm
Wednesday 10am - 5pm
Thursday 10am - 5pm
Friday 10am - 5pm

Website

Alerts

Be the first to know and let us send you an email when Recombinant DNA Technologies posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category